Sfoglia per AUTORE
BERRUTI A
Collezione ASL Biella

  

Items : 6

Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Jul;205:114088. doi: 10.1016/j.ejca.2024.114088. Epub 2024 Apr 26.

2024
ASL Biella
AOU San Luigi di Orbassano

Volante M; Palermo F; Sigala S; Rossini E; Saba L; Perotti P; Laganà M; Puglisi S; Cosentini D; Basile V; Grosso E; Tomaiuolo P; Scatolini M; Grisanti S; Berruti A; Terzolo M;

Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma Cells. in Endocrinology / Endocrinology. 2022 Feb 1;163(2):bqab248. doi: 10.1210/endocr/bqab248.

2022
ASL Biella

Sigala S; Hantel C; Berruti A; Grosso E; Scatolini M; Tiberio GAM; Fiorentini C; Grisanti S; Cosentini D; Tamburello M; Laganà M; Rossini E; Abate A; Memo M;

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Sep;155:127-135. doi: 10.1016/j.ejca.2021.06.034. Epub 2021 Aug 6.

2021
AO Cuneo
ASL Asti
ASL Biella
ASL Cuneo 2
AOU Città della Salute di Torino
ASL Città di Torino
AOU Novara

Masini C; Tucci M; Berruti A; Gennari A; Baier S; Ciccone G; Comandone A; Bellissimo AR; Montagnani F; Amoroso D; Sacco C; Chiappino I; Dal Canton O; Sirotova Z; Zamparini M; Valcamonico F; Vanella P; Fea E; Buttigliero C; Ortega C; Prati V; Dalla Volta A; Mosca A; Bianchi S;

Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients: A multicenter randomized phase III study of the Piemonte Oncology Network in Annals of Oncology

2020
ASL Biella
ASL Città di Torino
ASL Asti
AO Cuneo
ASL Cuneo 2
AOU Città della Salute di Torino

Fea E; Buttigliero C; Montagnani F; Comandone A; Gennari A; Tucci M; Chiappino I; Canton OD; Masini C; Sacco† C; Amoroso D; Sirotova Z; Ciccone G; Valcamonico F; Vanella P; Ortega C; Prati V; Bianchi S; Mosca A; Berruti A;

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 1998;41(4):333-8. doi: 10.1007/s002800050747.

1998
AOU San Luigi di Orbassano
ASL Biella
ASL Cuneo 2

Dogliotti L; Danese S; Berruti A; Zola P; Buniva T; Bottini A; Richiardi G; Moro G; Farris A; Baù MG; Porcile G;

Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival in Anticancer Research

1997
ASL Cuneo 1
ASL Biella
ASL Cuneo 2
AO Cuneo

Berruti A; Zola P; Buniva T; Baú MG; Farris A; Sarobba MG; Bottin A; Tampellini M; Durando A; Destefanis M; Monzeglio C; Moro G; Sussio M; Perroni D; Dogliotti L;